Länssjukhuset Ryhov

Jönköping 553 05

3 studies enrolling now · 10 studies all time

What they study most

Acute Myocardial Infarction, Alzheimer's Disease, Cerebrovascular Disease, Early Breast Cancer, Heart Failure With Preserved Ejection Fraction, Indolent Non-Hodgkin's Lymphomas, Intracerebral Haemorrhage, Intracerebral Hemorrhage, Intraventricular Hemorrhage, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Malignant Melanoma, Melanoma

Studies at this site

• International Care Bundle Evaluation in Cerebral Hemorrhage Research — Recruiting now
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed
• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early